Research

Our cancer and blood disease multidisciplinary teams apply the latest diagnostic tools and molecular analytics to optimize treatment recommendations. We provide a robust portfolio of clinical trials that bring promising new agents to our patients, including cellular and immune-based therapy.  We offer a Sickle Cell Disease program and an Adult Comprehensive Bleeding Disorders Center to complement our long-standing excellence in managing hemostatic and thrombotic disorders.